Muhammad N - Search Results

1

Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.

Muhammad N, Wang X, Wang K, Zhu C, Zhu Z, Jiao Y, Guo Z. Muhammad N, et al. Dalton Trans. 2016 Aug 16;45(33):13169-78. doi: 10.1039/c6dt01434h. Dalton Trans. 2016. PMID: 27333997

2

Metal-based anticancer chemotherapeutic agents.

Muhammad N, Guo Z. Muhammad N, et al. Curr Opin Chem Biol. 2014 Apr;19:144-53. doi: 10.1016/j.cbpa.2014.02.003. Epub 2014 Mar 5. Curr Opin Chem Biol. 2014. PMID: 24608084 Review.

3

Biotin-tagged platinum(iv) complexes as targeted cytostatic agents against breast cancer cells.

Muhammad N, Sadia N, Zhu C, Luo C, Guo Z, Wang X. Muhammad N, et al. Chem Commun (Camb). 2017 Sep 5;53(72):9971-9974. doi: 10.1039/c7cc05311h. Chem Commun (Camb). 2017. PMID: 28831477

4

Stimuli-Responsive Therapeutic Metallodrugs.

Wang X, Wang X, Jin S, Muhammad N, Guo Z. Wang X, et al. Among authors: muhammad n. Chem Rev. 2019 Jan 23;119(2):1138-1192. doi: 10.1021/acs.chemrev.8b00209. Epub 2018 Oct 9. Chem Rev. 2019. PMID: 30299085 Review.

5

Restraining Cancer Cells by Dual Metabolic Inhibition with a Mitochondrion-Targeted Platinum(II) Complex.

Wang K, Zhu C, He Y, Zhang Z, Zhou W, Muhammad N, Guo Y, Wang X, Guo Z. Wang K, et al. Among authors: muhammad n. Angew Chem Int Ed Engl. 2019 Mar 26;58(14):4638-4643. doi: 10.1002/anie.201900387. Epub 2019 Feb 27. Angew Chem Int Ed Engl. 2019. PMID: 30693616

6

Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1.

Jin S, Muhammad N, Sun Y, Tan Y, Yuan H, Song D, Guo Z, Wang X. Jin S, et al. Among authors: muhammad n. Angew Chem Int Ed Engl. 2020 Dec 14;59(51):23313-23321. doi: 10.1002/anie.202011273. Epub 2020 Oct 15. Angew Chem Int Ed Engl. 2020. PMID: 32897000

7

Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.

Jin S, Hao Y, Zhu Z, Muhammad N, Zhang Z, Wang K, Guo Y, Guo Z, Wang X. Jin S, et al. Among authors: muhammad n. Inorg Chem. 2018 Sep 4;57(17):11135-11145. doi: 10.1021/acs.inorgchem.8b01707. Epub 2018 Aug 17. Inorg Chem. 2018. PMID: 30117731

8

Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer.

Muhammad N, Tan CP, Nawaz U, Wang J, Wang FX, Nasreen S, Ji LN, Mao ZW. Muhammad N, et al. Inorg Chem. 2020 Sep 8;59(17):12632-12642. doi: 10.1021/acs.inorgchem.0c01736. Epub 2020 Aug 24. Inorg Chem. 2020. PMID: 32838518

9

Redirecting Cisplatin and Doxorubicin to Mitochondria Affords Highly Effective Platinum^IV Prodrug Against Triple Negative Breast Cancer.

Muhammad N, Cai-Ping T, Nasreen S, Mao ZW. Muhammad N, et al. Chem Asian J. 2021 Aug 16;16(16):2276-2279. doi: 10.1002/asia.202100593. Epub 2021 Jul 20. Chem Asian J. 2021. PMID: 34231967

10

Assessing the Impact of Early Nutritional Intervention on Pediatric Celiac Disease Management: A Prospective Cohort Study.

Muhammad N, Ahad A, Rashid N, Gul R, Tariq MA, Nazir A. Muhammad N, et al. Cureus. 2024 Dec 20;16(12):e76059. doi: 10.7759/cureus.76059. eCollection 2024 Dec. Cureus. 2024. PMID: 39835063 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

782 results

Search Page

Filters